Use of Staby^® technology for development and production of DNA vaccines free of antibiotic resistance gene

References

• Dubensky TW, Campbell BA, Villarreal LP. Direct transfection of viral and plasmid DNA into the liver or spleen of mice. Proc Natl Acad Sci U S A 1984; 81:7529 - 33; http://dx.doi.org/10.1073/pnas.81.23.7529; PMID: 6095303
   PubMed Web of Science ®Google Scholar
• Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247:1465 - 8; http://dx.doi.org/10.1126/science.1690918; PMID: 1690918
   PubMed Web of Science ®Google Scholar
• Liu MA, Ulmer JB. Human clinical trials of plasmid DNA vaccines. Adv Genet 2005; 55:25 - 40; http://dx.doi.org/10.1016/S0065-2660(05)55002-8; PMID: 16291211
   PubMed Web of Science ®Google Scholar
• Heller R, Shirley S, Guo S, Donate A, Heller L. Electroporation Based Gene Therapy–from the Bench to the Bedside. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Conference 2011; 2011:736-8.
   Google Scholar
• Vandermeulen G, Athanasopoulos T, Trundley A, Foster K, Préat V, Yáñez-Muñoz RJ, et al. Highly potent delivery method of gp160 envelope vaccine combining lentivirus-like particles and DNA electrotransfer. J Control Release 2012; 159:376 - 83; http://dx.doi.org/10.1016/j.jconrel.2012.01.035; PMID: 22310089
   PubMed Web of Science ®Google Scholar
• Satkauskas S, André F, Bureau MF, Scherman D, Miklavcic D, Mir LM. Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer. Hum Gene Ther 2005; 16:1194 - 201; http://dx.doi.org/10.1089/hum.2005.16.1194; PMID: 16218780
   PubMed Web of Science ®Google Scholar
• Liu MA, Wahren B, Karlsson Hedestam GB. DNA vaccines: recent developments and future possibilities. Hum Gene Ther 2006; 17:1051 - 61; http://dx.doi.org/10.1089/hum.2006.17.1051; PMID: 17032152
   PubMed Web of Science ®Google Scholar
• Moss RB. Prospects for control of emerging infectious diseases with plasmid DNA vaccines. J Immune Based Ther Vaccines 2009; 7:3; http://dx.doi.org/10.1186/1476-8518-7-3; PMID: 19735569
   PubMedGoogle Scholar
• Schalk JA, Mooi FR, Berbers GA, van Aerts LA, Ovelgönne H, Kimman TG. Preclinical and clinical safety studies on DNA vaccines. Hum Vaccin 2006; 2:45 - 53; http://dx.doi.org/10.4161/hv.2.2.2620; PMID: 17012886
   PubMed Web of Science ®Google Scholar
• Peubez I, Chaudet N, Mignon C, Hild G, Husson S, Courtois V, et al. Antibiotic-free selection in E. coli: new considerations for optimal design and improved production. Microb Cell Fact 2010; 9:65; http://dx.doi.org/10.1186/1475-2859-9-65; PMID: 20822537
   PubMed Web of Science ®Google Scholar
• Sodoyer R, Courtois V, Peubez I, Mignon C. Antibiotic-Free Selection for Bio-Production: Moving Towards a New “Golden Standard”. In: Pana M, ed. Antibiotic Resistant Bacteria - a Continuous Challenge in the New Millennium: InTech, 2012:531-48.
   Google Scholar
• Szpirer CY, Milinkovitch MC. Separate-component-stabilization system for protein and DNA production without the use of antibiotics. Biotechniques 2005; 38:775 - 81; http://dx.doi.org/10.2144/05385RR02; PMID: 15945374
   PubMed Web of Science ®Google Scholar
• Cherny I, Gazit E. The YefM antitoxin defines a family of natively unfolded proteins: implications as a novel antibacterial target. J Biol Chem 2004; 279:8252 - 61; http://dx.doi.org/10.1074/jbc.M308263200; PMID: 14672926
   PubMed Web of Science ®Google Scholar
• Guglielmini J, Szpirer C, Milinkovitch MC. Automated discovery and phylogenetic analysis of new toxin-antitoxin systems. BMC Microbiol 2008; 8:104; http://dx.doi.org/10.1186/1471-2180-8-104; PMID: 18578869
   PubMed Web of Science ®Google Scholar
• Hayes F, Van Melderen L. Toxins-antitoxins: diversity, evolution and function. Crit Rev Biochem Mol Biol 2011; 46:386 - 408; http://dx.doi.org/10.3109/10409238.2011.600437; PMID: 21819231
   PubMed Web of Science ®Google Scholar
• Hazan R, Sat B, Engelberg-Kulka H. Escherichia coli mazEF-mediated cell death is triggered by various stressful conditions. J Bacteriol 2004; 186:3663 - 9; http://dx.doi.org/10.1128/JB.186.11.3663-3669.2004; PMID: 15150257
   PubMed Web of Science ®Google Scholar
• Pandey DP, Gerdes K. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res 2005; 33:966 - 76; http://dx.doi.org/10.1093/nar/gki201; PMID: 15718296
   PubMed Web of Science ®Google Scholar
• Bernard P, Kézdy KE, Van Melderen L, Steyaert J, Wyns L, Pato ML, et al. The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase. J Mol Biol 1993; 234:534 - 41; http://dx.doi.org/10.1006/jmbi.1993.1609; PMID: 8254658
   PubMed Web of Science ®Google Scholar
• Salmon MA, Van Melderen L, Bernard P, Couturier M. The antidote and autoregulatory functions of the F plasmid CcdA protein: a genetic and biochemical survey. Mol Gen Genet 1994; 244:530 - 8; http://dx.doi.org/10.1007/BF00583904; PMID: 8078480
   PubMedGoogle Scholar
• Bernard P. Positive selection of recombinant DNA by CcdB. Biotechniques 1996; 21:320 - 3; PMID: 8862819
   PubMed Web of Science ®Google Scholar
• Vandermeulen G, Marie C, Scherman D, Preat V.. New Generation of Plasmid Backbones Devoid of Antibiotic Resistance Marker for Gene Therapy Trials. Molecular therapy. the journal of the American Society of Gene Therapy 2011; 19:1942 - 9; http://dx.doi.org/10.1038/mt.2011.182
   PubMed Web of Science ®Google Scholar
• Mettenleiter TC. Aujeszky’s disease (pseudorabies) virus: the virus and molecular pathogenesis--state of the art, June 1999. Vet Res 2000; 31:99 - 115; http://dx.doi.org/10.1051/vetres:2000110; PMID: 10726640
   PubMed Web of Science ®Google Scholar
• Eloit M, Gilardi-Hebenstreit P, Toma B, Perricaudet M. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. J Gen Virol 1990; 71:2425 - 31; http://dx.doi.org/10.1099/0022-1317-71-10-2425; PMID: 2172456
   PubMed Web of Science ®Google Scholar
• Marchioli CC, Yancey RJ Jr., Petrovskis EA, Timmins JG, Post LE. Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky’s disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells. J Virol 1987; 61:3977 - 82; PMID: 2824827
   PubMed Web of Science ®Google Scholar
• van Rooij EM, Rijsewijk FA, Moonen-Leusen HW, Bianchi AT, Rziha HJ. Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs. Vaccine 2010; 28:1808 - 13; http://dx.doi.org/10.1016/j.vaccine.2009.12.004; PMID: 20018271
   PubMed Web of Science ®Google Scholar
• Wathen LM, Platt KB, Wathen MW, Van Deusen RA, Whetstone CA, Pirtle EC. Production and characterization of monoclonal antibodies directed against pseudorabies virus. Virus Res 1985; 4:19 - 29; http://dx.doi.org/10.1016/0168-1702(85)90017-6; PMID: 3002067
   PubMed Web of Science ®Google Scholar
• Hong W, Xiao S, Zhou R, Fang L, He Q, Wu B, et al. Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets. Vaccine 2002; 20:1205 - 14; http://dx.doi.org/10.1016/S0264-410X(01)00416-9; PMID: 11803083
   PubMed Web of Science ®Google Scholar
• Yoon HA, Aleyas AG, George JA, Park SO, Han YW, Kang SH, et al. Differential segregation of protective immunity by encoded antigen in DNA vaccine against pseudorabies virus. Immunol Cell Biol 2006; 84:502 - 11; http://dx.doi.org/10.1111/j.1440-1711.2006.01463.x; PMID: 16869937
   PubMed Web of Science ®Google Scholar
• van Rooij EM, Haagmans BL, de Visser YE, de Bruin MG, Boersma W, Bianchi AT. Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs. Vet Immunol Immunopathol 1998; 66:113 - 26; http://dx.doi.org/10.1016/S0165-2427(98)00186-X; PMID: 9860185
   PubMed Web of Science ®Google Scholar
• Hwang DY, Lee JB, Kim TJ, Song JY, Hyun BH, Song CS, et al. Induction of immune responses to glycoprotein gD of Aujeszky’s disease virus with DNA immunization. J Vet Med Sci 2001; 63:659 - 62; http://dx.doi.org/10.1292/jvms.63.659; PMID: 11459012
   PubMed Web of Science ®Google Scholar
• Le Moigne V, Cariolet R, Béven V, Keranflec’h A, Jestin A, Dory D. Electroporation improves the immune response induced by a DNA vaccine against pseudorabies virus glycoprotein B in pigs. Res Vet Sci 2012; 93:1032 - 5; http://dx.doi.org/10.1016/j.rvsc.2011.09.020; PMID: 22051145
   PubMed Web of Science ®Google Scholar
• Gartner T, Romano M, Suin V, Kalai M, Korf H, De Baetselier P, et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine co-expressing pro-apoptotic caspase-3. Vaccine 2008; 26:1458 - 70; http://dx.doi.org/10.1016/j.vaccine.2007.12.056; PMID: 18280621
   PubMed Web of Science ®Google Scholar
• Bloquel C, Bejjani R, Bigey P, Bedioui F, Doat M, BenEzra D, et al. Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic efficacy using hTNF-alpha soluble receptor in uveitis. FASEB J 2006; 20:389 - 91; PMID: 16352651
   PubMed Web of Science ®Google Scholar
• van Meerloo J, Kaspers GJ, Cloos J. Cell sensitivity assays: the MTT assay. Methods Mol Biol 2011; 731:237 - 45; http://dx.doi.org/10.1007/978-1-61779-080-5_20; PMID: 21516412
   PubMedGoogle Scholar
• Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988; 115:61 - 9; http://dx.doi.org/10.1016/0022-1759(88)90310-9; PMID: 3192948
   PubMed Web of Science ®Google Scholar
• Vandermeulen G, Richiardi H, Escriou V, Ni J, Fournier P, Schirrmacher V, et al. Skin-specific promoters for genetic immunisation by DNA electroporation. Vaccine 2009; 27:4272 - 7; http://dx.doi.org/10.1016/j.vaccine.2009.05.022; PMID: 19450641
   PubMed Web of Science ®Google Scholar